Inspire Medical Systems Return on Investment 2017-2024 | INSP

Current and historical return on investment (ROI) values for Inspire Medical Systems (INSP) over the last 10 years.
Inspire Medical Systems ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-12-31 $0.04B 0.00%
2024-09-30 $0.01B 0.00%
2024-06-30 $-0.01B 0.00%
2024-03-31 $-0.04B 0.00%
2023-12-31 $-0.04B 0.00%
2023-09-30 $-0.05B 0.00%
2023-06-30 $-0.05B 0.00%
2023-03-31 $-0.05B -84.39%
2022-12-31 $-0.05B -39.58%
2022-09-30 $-0.05B -27.22%
2022-06-30 $-0.04B $0.24B -17.52%
2022-03-31 $-0.04B $0.24B -17.01%
2021-12-31 $-0.04B $0.25B -16.84%
2021-09-30 $-0.05B $0.24B -18.72%
2021-06-30 $-0.05B $0.24B -18.44%
2021-03-31 $-0.06B $0.25B -22.09%
2020-12-31 $-0.06B $0.25B -24.40%
2020-09-30 $-0.06B $0.25B -28.02%
2020-06-30 $-0.06B $0.26B -30.60%
2020-03-31 $-0.04B $0.15B -25.30%
2019-12-31 $-0.04B $0.16B -20.17%
2019-09-30 $-0.03B $0.17B -17.25%
2019-06-30 $-0.03B $0.18B -16.10%
2019-03-31 $-0.03B $0.18B -16.16%
2018-12-31 $-0.02B $0.19B -18.42%
2018-09-30 $-0.02B $0.12B -28.07%
2018-06-30 $-0.02B $0.13B -46.91%
2018-03-31 $-0.02B $0.02B -183.78%
2017-12-31 $-0.02B $0.02B -355.56%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.712B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.242B 54.20
Hims & Hers Health (HIMS) United States $14.325B 148.84
Tempus AI (TEM) United States $11.867B 0.00
IRhythm Technologies (IRTC) United States $4.463B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.134B 11.90
Clover Health Investments (CLOV) United States $1.737B 0.00
Schrodinger (SDGR) United States $1.735B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.312B 23.14
Azenta (AZTA) United States $1.277B 59.36
10x Genomics (TXG) United States $1.180B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.589B 0.00
Talkspace (TALK) United States $0.514B 153.50
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.433B 0.00
Claritev (CTEV) United States $0.405B 0.00
TruBridge (TBRG) United States $0.375B 831.67
Health Catalyst (HCAT) United States $0.299B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.208B 0.00
Nyxoah SA (NYXH) Belgium $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.156B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
American Well (AMWL) United States $0.119B 0.00
MDxHealth SA (MDXH) Belgium $0.084B 0.00
CareCloud (CCLD) United States $0.084B 3.19
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
Outset Medical (OM) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00